iRhythm Technologies (NASDAQ: IRTC) reported Q3 EPS of ($0.29), in-line with the analyst estimate of ($0.29). Revenue for the quarter came in at $25 million versus the consensus estimate of $23.87 million.

Guidance for Full Year 2017

iRhythm projects revenue for the full year 2017 to range from $96 to $97 million, gross margins for the full year 2017 to range from 71.5% to 72.5% and operating expenses for the full year 2017 to be between $93 and $95 million. This compares to previous guidance of $94 to $96 million in revenue, 71.5% to 72.5% in gross margins, and $89 and $92 million in operating expenses for the full year 2017 provided on August 2, 2017.

For earnings history and earnings-related data on iRhythm Technologies (IRTC) click here.